Boosted.ai
Unlocked design in code, allowing designers and agents to build production frontends. Led design for a zero-to-one retail investing app, with the design team building the entire React Native frontend. Delivered enterprise design projects that opened new partnerships and drove several million in revenue. Hired staff-level designers and a principal UX researcher to raise the team's craft and impact.
- Head of Design
- AI Finance
- 2025 to Current
9:41
AlfaB
What are you interested in?
Describe your own or pick a strategy to follow
Describe your ownTell us what you’re into
Or follow as many as you like
All sectors

+97


+97
Grid supply shortPower & Utilities · 23 stocks
Rising AI spendSemiconductors · 33 stocks
Optimus scales productionRobotics & Automation · 2 stocks
Cybersecurity more important than everCybersecurity · 13 stocks
AI reduces headcountArtificial Intelligence · 3 stocks
SMRs move to constructionPower & Utilities · 13 stocksContinue
Tellmewhatyou’reinto:asector,acompany,atrend,orahunchaboutwherethingsaregoing.
Try starting with one of these
Powering AI
Weight-loss drugs
Space
Prediction markets
TSLAGLP1
Thinking...
What’s your thesis?
Broader access to GLP-1 drugs grows demand as more patients stay on them
New GLP-1 uses beyond obesity and diabetes broaden the market
More GLP-1 competition puts pressure on pricing and market share
Broader access to GLP-1 drugs grows demand as more patients stay on them
Thinking...
Which stocks should it hold?

LLY
NVO
VKTX
RO
AMGN
GPCR
HIMSAddPick for meLLY, NVO, VKTX, AMGN, HIMS
Thinking...
Here’s your custom strategy
Want to create another strategy, or continue with this one?
Create anotherContinue
Describe what you’re intoWrite your own thesisName the stocks you wantOr answer in your own wordsGLP1
Add stocksDone
Search stocksHims
Suggested for your strategyStocks
LLYEli Lilly (LLY)
NVONovo Nordisk (NVO)
VKTXViking Therapeutics (VKTX)
RORoche (RO)
AMGNAmgen (AMGN)
HIMSHims & Hers Health, Inc.AA238490HIMS Co.,Ltd.
AAHIMSAAhimsa Industries Limited
Analyzingyournamesandtheupdatesthataffectyourstrategy
Wefound24updatesaffectingyournames





Filings, news and earnings for LLY...Filings, news and earnings for NVO...Filings, news and earnings for VKTX...Filings, news and earnings for AMGN...Filings, news and earnings for HIMS...
FollowingB
Trade recommendations that fit you
Alfa found 3 in these updates. Answer a few questions to unlock them.
Get recommendationsRecent updates
LLY2h agoLLY news report: Employer plans add coverage for obesity drugs
See Alfa’s trade recommendation
NVO4h agoNVO news report: Lower cash prices widen access to Wegovy
See Alfa’s trade recommendation
HIMS6h agoHIMS news report: Limits on compounded GLP-1s weigh on sales
See Alfa’s trade recommendation
VKTX9h agoVKTX news report: Oral obesity drug moves toward late-stage trials
See Alfa’s trade recommendation
9:41
AlfaB
What are you interested in?
Describe your own or pick a strategy to follow
Describe your ownTell us what you’re into
Or follow as many as you like
All sectors

+97


+97
Grid supply shortPower & Utilities · 23 stocks
Rising AI spendSemiconductors · 33 stocks
Optimus scales productionRobotics & Automation · 2 stocks
Cybersecurity more important than everCybersecurity · 13 stocks
AI reduces headcountArtificial Intelligence · 3 stocks
SMRs move to constructionPower & Utilities · 13 stocksContinue
Tellmewhatyou’reinto:asector,acompany,atrend,orahunchaboutwherethingsaregoing.
Try starting with one of these
Powering AI
Weight-loss drugs
Space
Prediction markets
TSLAGLP1
Thinking...
What’s your thesis?
Broader access to GLP-1 drugs grows demand as more patients stay on them
New GLP-1 uses beyond obesity and diabetes broaden the market
More GLP-1 competition puts pressure on pricing and market share
Broader access to GLP-1 drugs grows demand as more patients stay on them
Thinking...
Which stocks should it hold?

LLY
NVO
VKTX
RO
AMGN
GPCR
HIMSAddPick for meLLY, NVO, VKTX, AMGN, HIMS
Thinking...
Here’s your custom strategy
Want to create another strategy, or continue with this one?
Create anotherContinue
Describe what you’re intoWrite your own thesisName the stocks you wantOr answer in your own wordsGLP1
Add stocksDone
Search stocksHims
Suggested for your strategyStocks
LLYEli Lilly (LLY)
NVONovo Nordisk (NVO)
VKTXViking Therapeutics (VKTX)
RORoche (RO)
AMGNAmgen (AMGN)
HIMSHims & Hers Health, Inc.AA238490HIMS Co.,Ltd.
AAHIMSAAhimsa Industries Limited
Analyzingyournamesandtheupdatesthataffectyourstrategy
Wefound24updatesaffectingyournames





Filings, news and earnings for LLY...Filings, news and earnings for NVO...Filings, news and earnings for VKTX...Filings, news and earnings for AMGN...Filings, news and earnings for HIMS...
FollowingB
Trade recommendations that fit you
Alfa found 3 in these updates. Answer a few questions to unlock them.
Get recommendationsRecent updates
LLY2h agoLLY news report: Employer plans add coverage for obesity drugs
See Alfa’s trade recommendation
NVO4h agoNVO news report: Lower cash prices widen access to Wegovy
See Alfa’s trade recommendation
HIMS6h agoHIMS news report: Limits on compounded GLP-1s weigh on sales
See Alfa’s trade recommendation
VKTX9h agoVKTX news report: Oral obesity drug moves toward late-stage trials
See Alfa’s trade recommendation

